Skip to main content
Livermore
Livermore
ZHEN

Adaptimmune Therapeutics PLC

ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001621227

No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Adaptimmune Therapeutics PLC as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
68
−8 vs. Q2 2022
Shares held
113.9M
−872.6K (−0.8%) vs. Q2 2022
Total value
$122.4M
−$72.6M (−37.2%) vs. Q2 2022
New holders
10
20 more added
Sold out
18
15 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 68 institutions
Q1 2021: 84 institutionsQ2 2021: 82 institutionsQ3 2021: 92 institutionsQ4 2021: 85 institutionsQ1 2022: 80 institutionsQ2 2022: 77 institutionsQ3 2022: 68 institutionsQ4 2022: 69 institutionsQ1 2023: 65 institutionsQ2 2023: 89 institutionsQ3 2023: 79 institutionsQ4 2023: 79 institutionsQ1 2024: 80 institutionsQ2 2024: 76 institutionsQ3 2024: 81 institutionsQ4 2024: 80 institutionsQ1 2025: 67 institutionsQ2 2025: 65 institutionsQ3 2025: 55 institutionsQ4 2025: 10 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ3 2022: $122.4M
Q1 2021: $623.8MQ2 2021: $475.7MQ3 2021: $577.3MQ4 2021: $425.9MQ1 2022: $229.2MQ2 2022: $195.1MQ3 2022: $122.4MQ4 2022: $166.3MQ1 2023: $126.4MQ2 2023: $133.9MQ3 2023: $115.7MQ4 2023: $113.9MQ1 2024: $256.1MQ2 2024: $150.0MQ3 2024: $144.1MQ4 2024: $67.0MQ1 2025: $22.9MQ2 2025: $27.7MQ3 2025: $5.47MQ4 2025: $79.7KQ1 2026: $72Q2 2026: $0
Institutions holding ADAPY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$72
Q4 202510$79.7K
Q3 202555$5.47M
Q2 202565$27.7M
Q1 202567$22.9M
Q4 202480$67.0M
Q3 202481$144.1M
Q2 202476$150.0M
Q1 202480$256.1M
Q4 202379$113.9M
Q3 202379$115.7M
Q2 202389$133.9M
Q1 202365$126.4M
Q4 202269$166.3M
Q3 202268$122.4M
Q2 202277$195.1M
Q1 202280$229.2M
Q4 202185$425.9M
Q3 202192$577.3M
Q2 202182$475.7M
Q1 202184$623.8M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q2 2022.

Institutions holding ADAPY in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Harbour Investments, Inc.200$00.00%00.0%Unchanged
Royal Bank of Canada87$00.00%00.0%Unchanged
BNP Paribas Arbitrage, SA422$4540.00%−1,670−79.8%Reduced
Daiwa Securities Group Inc.469$1.00K0.00%−18,409−97.5%Reduced
Simplex Trading, LLC1,327$1.00K0.00%−12,230−90.2%Reduced
Advisor Group Holdings, Inc.1,250$1.00K0.00%00.0%Unchanged
Clearstead Advisors, LLC500$1.00K0.00%00.0%Unchanged
Carmichael Hill & Associates, Inc.525$1.00K0.00%00.0%Unchanged
Worth Asset Management, LLC600$1.00K0.00%00.0%Unchanged
Quadrant Capital Group LLC1,046$1.00K0.00%+1,046New
Aquatic Capital Management LLC1,100$1.00K0.00%+1,100New
China Universal Asset Management Co., Ltd.1,345$1.00K0.00%+1,345New
UBS Group AG1,984$2.00K0.00%−2,720−57.8%Reduced
Rockefeller Capital Management L.P.2,000$2.00K0.00%00.0%Unchanged
Signaturefd, LLC3,185$3.00K0.00%+2,413+312.6%Added
Lindbrook Capital, LLC3,084$3.00K0.00%+2,766+869.8%Added
Wells Fargo & Company6,200$6.00K0.00%00.0%Unchanged
Citigroup Inc6,649$7.00K0.00%−24,782−78.8%Reduced
Raymond James & Associates10,573$11.0K0.00%00.0%Unchanged
Running Point Capital Advisors, LLC10,000$11.0K0.01%00.0%Unchanged
Narwhal Capital Management10,344$11.0K0.00%+10,344New
Millennium Management LLC11,404$12.0K0.00%−110,718−90.7%Reduced
ProShare Advisors LLC12,085$13.0K0.00%+1,361+12.7%Added
Creative Planning12,878$14.0K0.00%+12,878New
US Bancorp16,049$18.0K0.00%+14,939+1,345.9%Added
Personal Cfo Solutions, LLC19,388$21.0K0.01%−3,000−13.4%Reduced
Captrust Financial Advisors19,622$21.0K0.00%+15,000+324.5%Added
RFG Advisory, LLC10,000$21.0K0.00%+10,000New
Group One Trading, L.P.21,032$23.0K0.00%+2,000+10.5%Added
Hunter Associates Investment Management LLC28,500$31.0K0.01%00.0%Unchanged
Janney Montgomery Scott LLC30,000$32.0K0.00%00.0%Unchanged
Stifel Financial Corp29,533$32.0K0.00%−121−0.4%Reduced
Tower Research Capital LLC (TRC)29,870$32.0K0.00%+486+1.7%Added
HBK Sorce Advisory LLC35,000$32.0K0.00%+35,000New
Two Sigma Advisers, LP31,100$33.0K0.00%−4,200−11.9%Reduced
SEI Investments Co31,287$34.0K0.00%+31,287New
Vigilare Wealth Management36,800$40.0K0.05%−5,000−12.0%Reduced
Virtu Financial LLC40,503$44.0K0.00%+23,175+133.7%Added
Geode Capital Management, LLC72,769$78.0K0.00%00.0%Unchanged
Alps Advisors Inc88,339$95.0K0.00%−7,771−8.1%Reduced
ACT Capital Management, LLC90,000$97.0K0.13%00.0%Unchanged
Acadian Asset Management LLC111,568$116.0K0.00%+97,980+721.1%Added
WS Management LLLP115,602$124.0K0.02%00.0%Unchanged
Kettle Hill Capital Management, LLC253,134$272.0K0.06%+253,134New
State Street Corp309,298$332.0K0.00%−57,227−15.6%Reduced
Barclays PLC340,068$366.0K0.00%+87,386+34.6%Added
DAFNA Capital Management LLC351,064$377.0K0.10%00.0%Unchanged
ExodusPoint Capital Management, LP370,288$398.0K0.01%+70,288+23.4%Added
Gsa Capital Partners LLP381,043$410.0K0.05%+381,043New
Rathbone Brothers plc432,818$465.0K0.01%00.0%Unchanged
Key Client Fiduciary Advisors, LLC435,985$469.0K0.48%+19,819+4.8%Added
Goldman Sachs Group Inc445,193$479.0K0.00%+83,092+22.9%Added
Renaissance Technologies LLC566,232$609.0K0.00%+56,232+11.0%Added
JPMorgan Chase & Co1,006,832$1.08M0.00%−467,331−31.7%Reduced
Bank of America Corp1,035,194$1.11M0.00%+43,750+4.4%Added
Syncona Portfolio Ltd1,377,294$1.48M2.57%00.0%Unchanged
BlackRock Inc.1,414,247$1.52M0.00%+47,340+3.5%Added
Citadel Advisors LLC1,537,686$1.65M0.00%+31,531+2.1%Added
FMR LLC1,578,783$1.70M0.00%00.0%Unchanged
Endurant Capital Management LP1,788,517$1.92M0.63%−35,548−1.9%Reduced
Morgan Stanley2,267,766$2.44M0.00%+187,297+9.0%Added
Rock Springs Capital Management LP2,357,544$2.53M0.07%00.0%Unchanged
Long Focus Capital Management, LLC4,789,490$5.15M1.09%+109,999+2.4%Added
PFM Health Sciences, LP9,320,584$10.0M0.38%+210,804+2.3%Added
Baker Bros. Advisors LP9,830,877$10.6M0.07%00.0%Unchanged
Baillie Gifford & Co14,664,936$15.8M0.02%−656,410−4.3%Reduced
NEA Management Company, LLC17,082,612$18.4M0.92%00.0%Unchanged
Matrix Capital Management Company, LP38,974,185$41.9M0.80%00.0%Unchanged
Point72 Asset Management, L.P.0$00.00%−647,008−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−217,123−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−134,912−100.0%Sold out
Erste Asset Management GmbH0$00.00%−90,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−44,086−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−43,966−100.0%Sold out
Crestline Management, LP0$00.00%−39,489−100.0%Sold out
Caxton Associates LP0$00.00%−23,034−100.0%Sold out
HRT Financial LP0$00.00%−21,091−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−15,232−100.0%Sold out
Engineers Gate Manager LP0$00.00%−14,294−100.0%Sold out
Itau Unibanco Holding S.A.0$00.00%−7,434−100.0%Sold out
Vectors Research Management, LLC0$00.00%−7,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−2,094−100.0%Sold out
Quantbot Technologies LP0$00.00%−2,000−100.0%Sold out
Blue Bell Private Wealth Management, LLC0$00.00%−759−100.0%Sold out
Joseph P. Lucia & Associates, LLC0$00.00%−375−100.0%Sold out
Cutler Group LP0$00.00%−400−100.0%Sold out
Exane Derivatives––––Not filed